511 related articles for article (PubMed ID: 9064988)
1. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Scholz H
Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Follath F; Candinas R; Frielingsdorf J
Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
[TBL] [Abstract][Full Text] [Related]
4. Class III antiarrhythmic drugs.
Singh BN; Ahmed R
Curr Opin Cardiol; 1994 Jan; 9(1):12-22. PubMed ID: 8199363
[TBL] [Abstract][Full Text] [Related]
5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
6. Class III antiarrhythmic agents: the next wave.
Bauman JL
Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
[TBL] [Abstract][Full Text] [Related]
7. The coming of age of the class III antiarrhythmic principle: retrospective and future trends.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):17-27. PubMed ID: 8780325
[TBL] [Abstract][Full Text] [Related]
8. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
Kuck KH
Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
[TBL] [Abstract][Full Text] [Related]
9. [Combination anti-arrhythmic drug therapy].
Lüderitz B; Jung W; Manz M
Z Kardiol; 1992; 81 Suppl 4():157-61. PubMed ID: 1283933
[TBL] [Abstract][Full Text] [Related]
10. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
11. [Antiarrhythmic agents: current situation].
Bonhorst D
Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
[TBL] [Abstract][Full Text] [Related]
12. [Ventricular arrhythmias: diagnosis and drug therapy].
Schüpfer C; Gertsch M
Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
14. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
15. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
[TBL] [Abstract][Full Text] [Related]
16. [New anti-arrhythmia agents].
Honerjäger P; Schmidt G
Z Kardiol; 1992; 81 Suppl 4():133-7. PubMed ID: 1363260
[TBL] [Abstract][Full Text] [Related]
17. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Brachmann J
Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
[TBL] [Abstract][Full Text] [Related]
18. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
Yap YG; Camm AJ
Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
[TBL] [Abstract][Full Text] [Related]
19. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
Candinas R; Bauersfeld U
Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
[TBL] [Abstract][Full Text] [Related]
20. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
